|
Glaxo submits new asthma drug application in Japan
MarketWatch LONDON–Pharmaceutical company GlaxoSmithKline PLC (GSK.LN) said Friday it has submitted a new drug application to the Japanese health ministry for mepolizumab, a drug used for treating a type of severe asthma. The application for mepolizumab has … Glaxo Submits Japan Application For Mepolizumab In Eosinophilic Asthma |
View full post on asthma – Google News